Showing items 921-930 of 2768 (277 Page(s) Totally)
<< < 88 89 90 91 92 93 94 95 96 97 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-12-29T03:08:51Z |
Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible enterococcus faecium bacteremia
|
Li H.-Y.; Chuang Y.-C.; Chuang Y.-C.;Li H.-Y.;Chen P.-Y.;Lin C.-Y.;Jann-Tay Wang;Chen Y.-C.;Chang S.-C.; Chen P.-Y.; Lin C.-Y.; JANN-TAY WANG; Chen Y.-C.; Chang S.-C. |
| 臺大學術典藏 |
2020-12-28T12:04:15Z |
Effects of obesity, physical activity, and cardiorespiratory fitness on blood pressure, inflammation, and insulin resistance in the National Health and Nutrition Survey 1999-2002
|
Lin C.-Y.; Chen P.-C.; Kuo H.-K.; Lin L.-Y.; Lin J.-W.; HWANG, JUEY-JEN |
| 臺大學術典藏 |
2020-12-28T10:02:48Z |
Identification of fibrillin-1 gene mutations in Marfan syndrome by high-resolution melting analysis
|
CHIH-CHIEH YU; Chiu H.-H.; Lin C.-Y.; Chang C.-H.; Cheng H.-Y.; Lee C.-N.; Hung C.-C.; Lin S.-Y.; Lin S.-P.; Cheng W.-F.; Ho H.-N.; Niu D.-M.; Su Y.-N. |
| 臺大學術典藏 |
2020-12-28T10:02:47Z |
Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndrome
|
Hung C.-C.; Lin S.-Y.; Lee C.-N.; Cheng H.-Y.; Lin S.-P.; Chen M.-R.; Chen C.-P.; Chang C.-H.; Lin C.-Y.; CHIH-CHIEH YU; Chiu H.-H.; Cheng W.-F.; Ho H.-N.; Niu D.-M.; Su Y. |
| 臺大學術典藏 |
2020-12-28T08:14:24Z |
Factors affecting the natural decay of hepatitis b surface antigen in children with chronic hepatitis b virus infection during long-term follow-up
|
Chang M.-H.; Hsu H.-Y.; Chiu Y.-C.; Liao S.-F.; Wu J.-F.; Lin C.-Y.; Lee W.-C.; Chen H.-L.; YEN-HSUAN NI |
| 臺大學術典藏 |
2020-12-28T08:14:14Z |
A targeted next-generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
|
Li H.-Y.; Fan S.-C.; Lin P.-H.; YEN-HSUAN NI; Chiu C.-F.; Yuan T.-H.; Chen M.; Hsu Y.-H.; Yang Y.-H.; Li L.-Y.; Yeh S.-P.; Bai L.-Y.; Liao Y.-M.; Lin C.-Y.; Hsieh C.-Y.; Lin C.-C.; Lin C.-H.; Lien M.-Y.; Chen T.-T. |
| 臺大學術典藏 |
2020-12-28T08:14:10Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N.; Lu S.-N.;Wang J.-H.;Su C.-W.;Wang T.-E.;Dai C.-Y.;Chen C.-H.;Chen R.-C.;Yang S.-S.;Hung C.-F.;Huang S.-F.;Liao L.-Y.;Huo T.-I.;Wu C.-C.;Lee P.-H.;Ting C.-T.;Lee W.-C.;Chau G.-Y.;Wang C.-C.;Lee K.-T.;Huang Y.-H.;Ho M.-C.;Lin S.-M.;Huang G.-T.;Chen K.-Y.;Lin X.-Z.;Hwang J.-I.;Chiou Y.-Y.;Wang C.-K.;Hu J.-T.;Chen S.-C.;Liang P.-C.;Lee R.-C.;Wu D.-K.;Lin C.-Y.;Lin C.-C.;Cheng A.-L.;Hsu C.;Chao Y.;Chen L.-T.;Wang P.-M.;Wang P.-M.;Hong J.-H.;Hsu H.-C.;Chen S.-W.;Leung S.W.;Cheng J.C.-H.;Wu J.-C.;Wu C.-Y.;Hsu Y.-C.;Hsu C.-W.;Yen-Hsuan Ni;Lin C.-L.;Local Ablation Group, Surveillance Group, Diagnosis Group, Staging Group, Surgery Group, Tace/Tare/Hai Group, Target Therapy/Systemic Therapy Group, Radiotherapy Group, Prevention Group, Drafting Group; Wang P.-M.; Chao Y.; Chen L.-T.; Hsu C.; Cheng A.-L.; Lin C.-C.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
| 臺大學術典藏 |
2020-12-24T08:38:30Z |
Primary aldosteronism: Changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment
|
Wu V.-C.;Kuo C.-C.;Wang S.-M.;Liu K.-L.;Huang K.-H.;Lin Y.-H.;Chu T.-S.;Chang H.-W.;Lin C.-Y.;Tsai C.-T.;Lin L.-Y.;Chueh S.-C.;Kao T.-W.;Chen Y.-M.;Wen-Chih Chiang;Tsai T.-J.;Ho Y.-L.;Lin S.-L.;Wang W.-J.;Wu K.-D.; Chen Y.-M.; WEN-CHIH CHIANG; Kao T.-W.; Chueh S.-C.; Lin L.-Y.; Tsai C.-T.; Wu V.-C.; Kuo C.-C.; Wang S.-M.; Liu K.-L.; Huang K.-H.; Lin Y.-H.; Chu T.-S.; Chang H.-W.; Lin C.-Y.; Tsai T.-J.; Ho Y.-L.; Lin S.-L.; Wang W.-J.; Wu K.-D. |
| 臺大學術典藏 |
2020-12-24T08:38:28Z |
Combining body mass index and serum potassium to urine potassium clearance ratio is an alternative method to predict primary aldosteronism
|
Kuo C.-C.;Wu V.-C.;Tsai C.-W.;Huang K.-H.;Wang S.-M.;Li B.-C.;Chang C.-C.;Lu C.-C.;Yang W.-S.;Chao C.-T.;Tsai I.-C.;Lai C.-F.;Lin W.-C.;Wu M.-S.;Lin Y.-H.;Lin C.-Y.;Chang H.-W.;Wang W.-J.;Wen-Chih Chiang;Kao T.-W.;Chueh S.-C.;Chu T.-S.;Tsai T.-J.;Wu K.-D.; Li B.-C.; Huang K.-H.; Wang S.-M.; Tsai C.-W.; Wu V.-C.; Kuo C.-C.; Tsai T.-J.; Chueh S.-C.; Chu T.-S.; Kao T.-W.; WEN-CHIH CHIANG; Wang W.-J.; Chang H.-W.; Lin C.-Y.; Chang C.-C.; Lu C.-C.; Yang W.-S.; Chao C.-T.; Tsai I.-C.; Lai C.-F.; Lin W.-C.; Wu M.-S.; Lin Y.-H.; Wu K.-D. |
| 臺大學術典藏 |
2020-12-24T08:11:49Z |
Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients
|
Lin H.-H.;Liou H.-H.;Ming-Shiou Wu;Lin C.-Y.;Huang C.-C.; Lin H.-H.; Liou H.-H.; MING-SHIOU WU; Lin C.-Y.; Huang C.-C. |
Showing items 921-930 of 2768 (277 Page(s) Totally)
<< < 88 89 90 91 92 93 94 95 96 97 > >>
View [10|25|50] records per page
